This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lehmann, A. K. Articles by Waage, A. Search for Related Content PubMed PubMed Citation Articles by Lehmann, A. K. Articles by Waage, A.

 Previous Article  |  Next Article 

Infect. Immun., 06 1995, 2109-2112, Vol 63, No. 6
Copyright © 1995, American Society for Microbiology

High levels of interleukin 10 in serum are associated with fatality in meningococcal disease

AK Lehmann, A Halstensen, S Sornes, O Rokke and A Waage
Medical Department B, University of Bergen, Norway.

Interleukin 10 (IL-10) suppresses the production of proinflammatory cytokines in vitro and in murine models of endotoxemia and has been suggested as a candidate for treatment of bacterial septicemia. To investigate the role of IL-10 in meningococcal disease, a sandwich IL- 10 enzyme-amplified sensitivity immunoassay was used to quantitate IL- 10 in serum and cerebrospinal fluid samples from 41 patients with meningococcal bacteremia or meningitis with or without septic shock. High levels of IL-10 were demonstrated in sera from patients with meningococcal septic shock (mean, 21,221 pg/ml; range, 25 to 64,500 pg/ml). All cases involving fatalities had IL-10 levels in serum of > or = 1,000 pg/ml (mean, 23,058 pg/ml; range, 1,000 to 64,500 pg/ml). Patients with meningococcal meningitis without septic shock had comparably low concentrations of IL-10 in serum (mean, 119 pg/ml; range, 0 to 1,050 pg/ml) but exhibited compartmentalized release of IL- 10 in cerebrospinal fluid. Concentrations of IL-10 in serum were positively correlated with the previously reported concentrations of tumor necrosis factor alpha, IL-6, and IL-8 in serum in the same patients. We conclude that IL-10 is extensively activated along with the proinflammatory cytokines during the initial phase of meningococcal septic shock and that IL-10 is associated with fatality in meningococcal disease.

This article has been cited by other articles:

• Lighter, J., Tse, D. B., Kaul, A., Borkowsky, W. (2008). Hyper Interleukin-10 in an HIV-Positive Child With T-Cell Lymphoma and Candidal Sepsis. J Int Assoc Physicians AIDS Care (Chic Ill) 7: 228-231 [Abstract]  
• Londono, D., Marques, A., Hornung, R. L., Cadavid, D. (2008). IL-10 Helps Control Pathogen Load during High-Level Bacteremia. J. Immunol. 181: 2076-2083 [Abstract] [Full Text]  
• Perez, N, Regairaz, L, Bustamante, J, Osimani, N, Bergna, D, Morales, J, Agosti, M R, Gonzalez-Ayala, S, Peltzer, C, Rodrigo, A (2007). Severity of meningococcal infections is related to anthropometrical parameters. Arch. Dis. Child. 92: 790-794 [Abstract] [Full Text]  
• Naldini, A., Bernini, C., Pucci, A., Carraro, F. (2005). Thrombin-mediated IL-10 up-regulation involves protease-activated receptor (PAR)-1 expression in human mononuclear leukocytes. J. Leukoc. Biol. 78: 736-744 [Abstract] [Full Text]  
• Johansson, L., Rytkonen, A., Wan, H., Bergman, P., Plant, L., Agerberth, B., Hokfelt, T., Jonsson, A.-B. (2005). Human-Like Immune Responses in CD46 Transgenic Mice. J. Immunol. 175: 433-440 [Abstract] [Full Text]  
• Lee, S. J. (2005). New approaches for preventing and treating chronic graft-versus-host disease. Blood 105: 4200-4206 [Abstract] [Full Text]  
• Ashare, A., Powers, L. S., Butler, N. S., Doerschug, K. C., Monick, M. M., Hunninghake, G. W. (2005). Anti-inflammatory response is associated with mortality and severity of infection in sepsis. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L633-L640 [Abstract] [Full Text]  
• Jiang, B, Snipes-Magaldi, L., Dennehy, P., Keyserling, H., Holman, R. C., Bresee, J., Gentsch, J., Glass, R. I. (2003). Cytokines as Mediators for or Effectors against Rotavirus Disease in Children. CVI 10: 995-1001 [Abstract] [Full Text]  
• Bjerre, A., Brusletto, B., Ovstebo, R., Joo, G. B., Kierulf, P., Brandtzaeg, P. (2003). Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex. Innate Immunity 9: 155-163 [Abstract]  
• Royston, D., Kovesi, T., Marczin, N. (2003). The unwanted response to cardiac surgery: Time for a reappraisal?. J. Thorac. Cardiovasc. Surg. 125: 32-35 [Full Text]  
• Antunes, G., Evans, S.A., Lordan, J.L., Frew, A.J. (2002). Systemic cytokine levels in community-acquired pneumonia and their association with disease severity. Eur Respir J 20: 990-995 [Abstract] [Full Text]  
• Alcaraz, A. J., Sancho, L., Manzano, L., Esquivel, F., Carrillo, A., Prieto, A., Bernstein, E. D., Alvarez-Mon, M. (2002). Newborn patients exhibit an unusual pattern of interleukin 10 and interferon {gamma} serum levels in response to cardiac surgery. J. Thorac. Cardiovasc. Surg. 123: 451-458 [Abstract] [Full Text]  
• Brandtzaeg, P., Bjerre, A., Ovstebo, R., Brusletto, B., Joo, G. B., Kierulf, P. (2001). Invited review: Neisseria meningitidis lipopolysaccharides in human pathology. Innate Immunity 7: 401-420 [Abstract]  
• HACKETT, S.J., THOMSON, A.P. J., HART, C.A. (2001). Cytokines, chemokines and other effector molecules involved in meningococcal disease. J Med Microbiol 50: 847-859 [Abstract] [Full Text]  
• Opal, S. M., DePalo, V. A. (2000). Anti-Inflammatory Cytokines. Chest 117: 1162-1172 [Abstract] [Full Text]  
• van Deuren, M., Brandtzaeg, P., van der Meer, J. W. M. (2000). Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management. Clin. Microbiol. Rev. 13: 144-166 [Abstract] [Full Text]  
• Eskdale, J., Gallagher, G., Verweij, C. L., Keijsers, V., Westendorp, R. G. J., Huizinga, T. W. J. (1998). Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc. Natl. Acad. Sci. USA 95: 9465-9470 [Abstract] [Full Text]  
• van Deuren, M., van der Ven-Jongekrijg, J., Vannier, E., van Dalen, R., Pesman, G., Bartelink, A. K.M., Dinarello, C. A., W.M. van der Meer, J. (1997). The Pattern of Interleukin-1beta (IL-1beta ) and Its Modulating Agents IL-1 Receptor Antagonist and IL-1 Soluble Receptor Type II in Acute Meningococcal Infections. Blood 90: 1101-1108 [Abstract] [Full Text]